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PREFACE
Recovering from a substance use disorder is challenging, and there are fewer
environments more challenging than a college campus. Since the late 70s and early 80s
college campuses have been experimenting with programs to build communities of support
for students in recovery from addiction, but growth has been slow and haphazard. Similarly,
slow and haphazard growth among recovery community organizations and other peer-based
recovery support services have begun to build a backbone of recovery infrastructure across
the country. Many factors contribute to stymied growth of these promising programs, but
chief among them is the patchy evidence base for the efficacy and efficiency of these
programs. This thesis represents an attempt to begin to fill one such gap, and to provide an
additional tool for advocates and decision-makers, as well as those seeking guidance on how
to improve efficiency in existing programs.
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The prevalence of substance use disorders (SUDs) is greater among full-time college
students and young adults regardless of enrollment status than it is among any other age
group (1,2). These disorders represent substantial costs to both society and to institutions of
higher education, both in terms of life years lost and in lost tuition revenue. The recent
proliferation of collegiate recovery programs (CRPs) – supportive communities and resource
centers for students seeking to maintain SUD recovery while pursuing a higher education –
have the potential to help ameliorate some of these costs. While these CRPs are typically
low-cost compared to acute care, a cost-effectiveness analysis of these programs has not yet
been undertaken. In a comprehensive cost-effectiveness analysis, these programs were found
to be cost-effective by the standards of the cost-effectiveness reference case from the societal
perspective, and in line with the cost-effectiveness of other college health and wellness
programs from the institutional perspective (3,4). In addition to being cost-effective, CRPs
represent a cost savings to society and institutions across a wide range of variation.
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BACKGROUND
Literature Review
Prevalence of Substance Use Disorder Among College Students
Substance use disorder (SUD) represents a pressing public health concern, with an
estimated 19.7 million Americans (7.2% of the population) affected (2). The prevalence of
this condition is higher among young adults (18 to 25 years old) than in any other age group,
with young adult prevalence at 15.1%, nearly double the national prevalence (7.5%), more
than double the prevalence among adults over 26 (6.6%), and more than triple the prevalence
among adolescents (4.4%) (5). The 5.2 million young adults with a SUD represent 25.8% of
the total population of individuals with SUD (2).
In the US, 45,296 died in 2016 as a direct result of SUD (6). Those lives lost
translated to 1,872,646 years of life lost, and over 4.8 million disability adjusted life years in
2016 (6). The overall costs to society of SUD are $442 billion annually (7–9). In addition to
the substantial toll of SUD, drug overdose fatalities rose to a record high of 70,237 in 2017,
largely driven by the continuation of the opioid public health emergency (10). SUD is
particularly prevalent among American Indian or Alaska Native populations (12.8%) and
those who identify as belonging to two or more races (9.7%), while the greatest number of
SUD cases are among non-Hispanic Whites at 13.1 million (1).
Over half of American adults (58.9%) have attended some college or more (11), and
many (40.5%) young adults are enrolled in college every year (12). The college environment
can be particularly challenging for those who struggle with substances, especially for those
who meet the criteria for SUD. Among 18 to 22-year old undergraduate students who were
1

enrolled full time in college, 14.7% met the criteria for substance use disorder in 2016 (13).
Prevalence was slightly higher among 18 to 22 year old young adults who were not enrolled
in college at 15.1% (13).
Of particular concern is the gap between perceived substance use and actual
substance use among college-aged peers. Undergraduates believe that over 93% of their
peers drank alcohol in the last 30 days, when in reality only 58.9% did (14). This disparity
was even more pronounced for marijuana use: undergraduates believed that 83.5% of their
peers consumed marijuana in the past 30 days, but only 18.1% did (14). This disparity
between perceived substance use patterns and actual substance use patterns can lead a college
student struggling with SUD to resist seeking help, to normalize problematic substance use,
or to experience feelings of isolation when pursuing recovery (15). When only 7.2% of
young adults who need SUD treatment receive it (16), removing some of the barriers to
seeking and receiving help is essential, and there is high potential to reach these individuals
on college campuses.
Collegiate Recovery Programs
Collegiate recovery programs (CRPs) developed to aid college students in or seeking
recovery from SUDs by providing social support and access to recovery-supportive
resources. These programs are housed on college campuses, typically as part of health or
counseling services, or within student affairs divisions (17). CRPs consist of four
components: a community of students in recovery from addiction, recovery-supportive
programming (e.g. peer support meetings, sober social activities, service work), and a
dedicated space supported by dedicated staff, which is often limited to one or two full-time
2

employees (18,19). Process evaluation studies of CRPs have found a variety of practices,
including core functional activities that fall into the four key components described above, as
well as additional practices that reflect campus cultural variation (17).
Outcome evaluation studies demonstrate that students currently in CRPs experience
lower relapse rates (8%) than the general population in SUD recovery (40-60%), and the
lower relapse rates are preserved among alumni of these programs (10.2%), as well (20–22).
In addition to their core function of supporting individual students in recovery, these
programs typically serve as educational resources, as well, aiming to shift the norms around
substance use on college campuses, potentially easing barriers to help-seeking for young
adults struggling with SUDs (18,23).
While CRPs have existed since the late 1970s, the recent rapid growth of the field
from approximately 29 programs in 2012 to over 184 programs in 2018 has resulted in a
significant gap between the popularity and proliferation of these programs, and the evidence
of their support, though what evidence exists is promising (17,18,20,21). The literature on
CRPs represents only part of the evaluation hierarchy. The evaluation hierarchy is a
framework for understanding the critical components necessary to plan, implement and
assess effective programs, with needs assessment forming the bottom tier, followed by an
assessment of program design and theory, program process and implementation, and program
outcome or impact (24). An assessment of program cost and efficiency forms the final tier of
the evaluation hierarchy (24). To date no efficiency evaluations of CRPs have been
conducted. Efficiency evaluations are critical for both policymakers and higher education
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administrators to decide whether these programs are a sound investment for their state or
institution.
It is expected that these programs will be cost-effective, even when future benefits are
discounted to account for the young age of the target population, because CRPs can be
operated relatively inexpensively (19). The production function of CRPs is to facilitate peer
support, and thus many of the most critical functions – peer support meetings, sober social
activities, etc. – are driven by the students in recovery, themselves. Other peer support-based
programs, such as Texas’ Peer Recovery Support Services demonstration project, have
provided extensive cost savings by reducing hospitalizations, involuntary admissions and
readmissions for individuals with either SUDs, mental health conditions, or both (25,26). It is
expected that CRPs will prove to be similarly cost-effective and lead to substantial savings
both for society and institutions of higher education.
Public Health Significance
Treatment of SUDs is costly. Each treatment episode is estimated to cost between
$15,227 and $22,436 in 2006 and 2010 dollars adjusted for inflation (27–29). Over 63% of
individuals admitted for substance use disorder treatment in 2015 had at least one previous
treatment episode, and 15.5% had five or more previous treatment episodes, thus it is
critically important to improve recovery support and relapse prevention infrastructure to
reduce the amount of repeat treatment episodes (30).
Relapse rates for the general SUD population are between 40% to 60%, which is
comparable to other chronic diseases such as type 1 diabetes (30% - 50%) and hypertension
or asthma (50% - 70%), though this relapse rate does not account for those who may return to
4

substance use, but at levels that do not meet the criteria for SUD (22). Relapse rates among
CRP participants are much lower, in contrast, at only 8% on average (range 0% - 25%), and
these lower rates are maintained among program alumni (20,21). The protective effects of
participating in peer-based recovery support in a naturalistic, community setting has also
been observed in peer recovery support services and for adolescents in recovery high schools,
thus there are multiple lines of evidence – some emerging, some well-established –
supporting the efficacy of peer-based recovery support services delivered in a variety of
settings (25,31). With treatment costs continuing to rise, a rise in mortality risk upon relapse
due to the infiltration of powerful synthetic opioids into street drugs, it is particularly
important to provide cost-effective recovery support resources in the communities and
institutions where people in recovery may be most challenged (32). Due to outsized
perceptions of substance use prevalence on college campuses described above, college
campuses may be among the most challenging environments for people in recovery from
SUD, as well as one of the most important opportunities for early intervention and secondary
prevention due to the generally young age of college populations (14).
Much of the existing literature on CRPs are descriptive studies or outcome evaluation
studies, and may use traditional SUD outcome metrics such as relapse rates, comparable
college health statistics, or recovery capital (20,21,33,34). To date, no efficiency evaluation
studies of CRPs exist in the published literature, thus a cost-effectiveness analysis is needed
to provide context to the promising health outcomes described in other studies.
The threshold for cost-effectiveness from the societal perspective is by convention set
at $50,000 per quality-adjusted life year (QALY) added by the intervention in question, but
5

the origins and continued utility of this threshold is in question (35,36). Current
recommendations from the Second Panel on Cost-Effectiveness in Health and Medicine call
for thresholds to be tied to comparable treatments that can best be understood by decisionmakers (4). In this case, the threshold for comparison can be set at treatment as usual (TAU),
or the cost of additional treatment episodes, wherein college students attend treatment offcampus and do not participate in a CRP. It may also be useful to compare the costeffectiveness of CRPs to the cost-effectiveness of other college health programs for the
institutional perspective. For example, the cost-effectiveness of Hepatitis A/B vaccinations
for college students is considered cost-effective at $8,500 per QALY (37). From the
institutional perspective, the cost per student retained who would otherwise have been lost to
substance-use related attrition is the effect or outcome of interest, rather than QALY.
Objectives
The purpose of this study is to determine whether CRPs meet the criteria for costeffectiveness described above. A secondary objective of this study is to design and
disseminate a Cost-Effectiveness Toolkit for CRPs based on this comprehensive analysis that
will allow advocates to conduct their own basic cost-effectiveness analysis of an existing or
proposed CRP.

6

METHODS
The reference case described by the First and Second Panel on Cost-Effectiveness in
Health and Medicine provide a standard framework and methodology for conducting costeffectiveness analyses from the perspective of society and the healthcare system (3,4). For
the cost-effectiveness analysis of CRPs from the societal perspective, the analysis will follow
the reference case guidelines; however, some adjustments must be made for the analysis from
the institutional perspective.
Study Design
Cost-effectiveness analysis involves the calculation of an intervention’s costs per unit
of desired health outcome gained. The cost under a TAU scenario is subtracted from the cost
under the intervention condition, in this case the cost of providing a CRP at an institution of
higher education (3). This net cost is then divided by units of desired health outcome gained
by the intervention, or the intervention’s effect (3). This general cost-effectiveness formula is
presented in figure 1.

Figure 1. The general cost-effectiveness formula.
!"#$ "& '($)*+)($,"( − !"#$ "& .*)/$0)($ /# 1#2/3
'($)*+)($,"( 4&&)5$ − .*)/$0)($ /# 1#2/3 4&&)5$
In the case of a traditional cost-effectiveness analysis from the societal perspective,
the desired health outcome is quality-adjusted life years (QALYs) gained, which are used in
this study as the outcome of interest for the societal perspective model (3). The Second Panel
on Cost-Effectiveness recommends examining cost-effectiveness from both the perspective
7

of society and from the perspective of the healthcare system (4). Here, college and university
campuses are substituted for the healthcare system perspective, as the burden of adopting
CRPs as an intervention lies with these institutions. From this institutional perspective, the
outcome of interest selected is the number of students retained who would otherwise be lost
to substance use-related attrition. The costs to key campus resources and tuition lost to
substance-related attrition represent the costs under the TAU scenario. Univariate and
multivariate sensitivity analyses were conducted to account for uncertainty in both the
societal and institutional perspective models (3).
Study Setting
Data on costs associated with CRPs were gathered from two national surveys of CRP
staff and administrators conducted in 2015 and 2017, and used with permission of the authors
(17,19). Of the 54 schools involved in the study by Jones and colleagues, 53 were located
within a 4-year college or university, while one was categorized as a 2-year junior or
community college (19). Most (81.5%) of the schools were public universities, while the rest
(18.5%) were private (19). The Transforming Youth Recovery survey identified 184
institutions offering a CRP; however, data on type of college or university (e.g. public,
private, 2-year, 4-year) were not collected (17).
Both surveys were cross-sectional in nature, and relied on self-reporting from CRP
staff (17,19). Validity and reliability analyses were not reported for either survey instrument.
The survey conducted by Jones and colleagues was limited to institutional members of the
Association of Recovery in Higher Education, the national professional organization for
CRPs, while the Transforming Youth Recovery survey was administered to the
8

organization’s grantees, recipients of technical assistance, and others identified as potentially
having recovery support on campus (17,19).
Outcomes data on CRPs were drawn from a national cross-sectional study of CRP
student participants (n = 486, programs represented = 29) conducted in 2012 by Laudet and
colleagues, which reports average relapse rates along with relapse rate ranges for responding
programs (20). Additional data sources for both the societal and institutional perspectives
were drawn from the existing literature and are described below, and in tables 1 and 2.
Data Collection
Estimating Costs
From the societal perspective, the total cost to society of SUD was found in the
Surgeon General’s Report on Alcohol, Drugs, and Health, and is estimated to be $442 billion
(7–9). To capture only the portion of societal costs attributable to college students with SUD,

Table 1. Variables for the CRP CEA societal perspective model.
Variable Description
C
The portion of the total financial cost to society of SUD
attributable to full-time undergraduate college students aged
18-22.
Ci
Cost of SUD per individual in the target population.
B
CRP budget
M
Mean CRP membership
R
Percent of students who experience a relapse.
Y
Number of years of quality-adjusted life expectancy in either
the TAU or CRP condition.

Source
(1,7–9)
(1,7–9)
(19)
(17)
(20)
(6,38)

the total societal cost was multiplied by the proportion of the total SUD population that
college students represent, which is approximately 0.052 (1). Thus, the total cost to society of
9

SUD among college students in one year is estimated to be $23,019,898,477.16, which
represents the TAU condition. The per-person cost of college student SUD (variable Ci was
found by dividing the cost of college student SUD by the number of college students with
SUD, and was $22,436.55 per student. The formula for estimating the cost of TAU from the
societal perspective is shown in figure 2.

Figure 2. The cost of TAU from the societal perspective.
! = ."$/3 !"#$ $" 7"5,)$8 ∗

:20;)* "& 5"33)<) #$2=)($# >,$ℎ 71@
:20;)* "& A0)*,5/(# >,$ℎ 71@

Estimating costs for the societal perspective intervention condition involves several
assumptions. First, that a student who is participating in a CRP is not adding to the total
societal costs, thus the per-person cost of SUD attributable to that student must be subtracted
from the total cost to society. The second assumption is that only direct costs will be of
interest to stakeholders, thus opportunity costs that CRP participants might incur will not be
included in the model. The only direct cost to consider in this case is the CRP’s budget. CRP
budgets were estimated from the Jones and Eisenhart data set (19). Twenty CRPs provided
sufficient information about staff salaries and the proportion of the overall budget that
salaries represented in order to solve for an estimated total budget for the CRP (19). Thus,
intervention costs are the total costs to society with the savings attributed to CRP participants
subtracted, plus the average estimated budget for a CRP. The estimated number of CRP
participants is adjusted to account for the average 8% relapse rate (20). Mean membership
size for CRPs were estimated from a survey of 124 CRPs (17). Respondents reported
10

membership size categorically, and true membership sizes were either interval censored (“6
to 10 members”) or right censored (“51+ members”), and thus the true mean of membership
sizes cannot be known from this dataset. To obtain an estimated mean for use in the base case
models, the right-censored category was converted to an interval (“51 to 60 members”) and
the midpoint of each interval was used to calculate a mean. The converted right-censored
category is an overly conservative estimate: the largest CRPs serve as many as 100 students
or more (39). While many CRPs also serve a vital function as health educators and resource
brokers on their campuses, serving hundreds or thousands of students through education,
training, or referrals, this CEA will be limited to accounting for their core function of
recovery support. Figure 3 represents the estimated cost of the intervention condition.

Figure 3. Estimated cost of the intervention condition.
! − BC ∗ (1 − F)H + J
From the institutional perspective, total costs include the cost of lost tuition revenue
due to substance use-related attrition, and the opportunity costs of campus staff handling
substance use-related cases. Substance use-related attrition is estimated to account for
approximately 10% to 20% of general attrition, and 15% is used for the base model (40). The
average general attrition rate is 24.7% (41). The average cost of annual tuition across all
institutions is $26,120 (42). With an average undergraduate enrollment size of 4,551, the
tuition revenue lost to substance-related attrition is just over $5.8 million at an average
institution (43). Figure 4 presents the formula for estimating tuition lost to substance userelated attrition.
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Figure 4. Estimation of tuition lost to substance use-related attrition.
. ∗ 4 ∗ K)()*/3 A$$*,$,"( F/$) ∗ 72;#$/(5) F)3/$)= A$$*,$,"( F/$)

Opportunity costs for the institutional perspective are estimated by first finding the average
hourly pay for three types of campus staff frequently responsible for handling substancerelated cases: student conduct officers (44), counselors (45), and campus law enforcement
officers (46). Drug and alcohol-related incidents occurring on college campuses must be
tracked and reported in a biennial review as required by the Drug-Free Schools and
Communities Act (47). These incidents include both referrals to student conduct officers for
drug and alcohol-related offenses, as well as on-campus arrests involving substances (43). To
find the number of referrals and arrests attributable to a particular school, the proportion of
the college population that the school represents is found by dividing the number of students
at the school by the total number of undergraduate college students enrolled in a given year.
This proportion is then multiplied by the number of referrals and arrests to find the
approximate number attributable to the school. To find the total opportunity costs for student
conduct referrals and arrests, the estimated number of cases is multiplied by the average
hourly wage for student conduct officers and campus police officers. This approach likely
underestimates opportunity costs, as it assumes only one hour of a staff person’s time per
case. Figure 5 presents the formula for estimating opportunity costs associated with arrests
and student conduct incidents related to substance use.

12

Table 2. Variables for the CRP CEA institutional perspective model.
Variable Name
Description
A
Attrition
Tuition lost to substance-related attrition
annually.
As
Attrition rate
Rate of substance-related attrition.
(substancerelated)
Ag
Attrition rate
Rate of general attrition.
(general)
Os
Opportunity
The opportunity cost of Student Conduct staff
cost – Student working cases attributed to substance use.
Conduct
Oc
Opportunity
The opportunity cost of counseling center staff
cost –
seeing patients for substance use-related
counseling
sessions.
services
Oa
Opportunity
The opportunity cost of law enforcement for
cost – arrests
substance-related arrests on campus.
Ss,c,a
Per-student
Per-student opportunity cost for each type of
opportunity
opportunity cost described above.
cost
E
Enrollment
Undergraduate enrollment.
T
Tuition
Cost of tuition for 1 year.

Source
(40,41)

(43,44)
(48,49)

(43,46)
See above
(43)
(42)

Figure 5. Estimation of opportunity costs associated with arrests and student conduct
incidents involving substance use.
LM,O = 7$/&& P/<) ∗ (."$/3 :20;)* "& '(5,=)($# ∗

4(*"330)($ 7,Q)
)
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The method for calculating the opportunity costs for counselors is different because
substance-related counseling appointments are not required to be tracked under the DrugFree Schools and Communities Act. First, the average percent of the student body served by
the counseling center was identified as 12%, though the range of variation is wide (1% to
74%) (48). Next, the prevalence of substance-related problems among students presenting to
the counseling center for treatment was found (11%), as well as the average number of
13

sessions per client, which was 5.5 (49). Thus, the number of counseling sessions attributable
to substance use disorder is a function of the enrollment size, and this number of sessions is
multiplied by the average hourly wage for counselors. This is also likely to be an
underestimate, as the costs captured here represent only the time spent in session with the
student and does not capture time spent on associated paperwork or case management. Figure
6 presents the estimation of opportunity costs associated with counseling for students with
substance-related problems.

Figure 6. Estimation of opportunity costs for students seeking counseling services for
substance-related problems.
LS = 4 ∗ % 7$2=)($# 7)*+)= ∗ % 72;#$/(5) 1#) !/#)# ∗ # 7)##,"(#

To estimate the cost of TAU, the total opportunity costs are added to the cost of
substance-related attrition. To estimate the cost of the intervention condition, the cost
attributable to each student who is participating in the CRP and is assumed to not be adding
to these lost tuition costs or opportunity costs, is subtracted from the cost of TAU, and
adjusted to account for relapse. The cost of the CRP budget is also included in the cost of the
intervention condition. Figure 7 represents the estimation of the cost of TAU and the cost of
the intervention condition from the institutional perspective.
Estimating Effect
For the societal model, the outcome of interest, or effect for which the cost is being
calculated, is the QALY (3,4). Measuring SUD-related quality of life is challenging, and may
14

vary widely depending on the type of drug an individual primarily consumes, their
socioeconomic status, co-occurring mental or physical health conditions, and other

Figure 7. Institutional model cost of TAU and cost of intervention condition.
.A1 = A + LS + LM + LO
'($)*+)($,"( = J + .A1 − B(C ∗ 1 − F) ∗ .H − U 7M,S,O ∗ C ∗ (1 − F)

demographic and life history factors, but more comprehensive measures of recovery capital
do not directly translate into life years (6,50–53). Here, disability weights for different kinds
of SUD (e.g. alcohol use disorder, opioid use disorder, etc.) from the Global Burden of
Disease study were averaged for an aggregate SUD disability weight (6). Disability weights
are effectively the inverse of a quality of life adjustment, and may be converted to use for the
calculation of QALYs by subtracting the disability weight from 1 (54). The average quality
of life adjustment was 0.586 (see table 3), but variable, with a range of 0.741 to 0.359 (6,54).
The quality of life adjustment was then entered into Muennig’s quality-adjusted life
expectancy calculator to find the new life expectancy for the two relevant age cohorts (ages
15 to 19 and 20 to 24), and the difference between the SUD condition life expectancy and the
good health condition life expectancy was averaged for the two groups (38). The average
QALYs gained were 25.2 years.
The institutional perspective is concerned with students retained who would
otherwise have been lost to attrition as a measure of program effect. Part of the formula used
to calculate the cost of substance-related attrition was used to calculate student attrition: the
15

Table 3. Health-related quality of life adjustments for substance use disorder, calculated from
Whiteford et al., 2013.
Condition
Disability Weight
CI
QOL Adjustment
AUD - Mild
0.259
(0.176-0.359)
0.741
AUD - Moderate
0.388
(0.262-0.529)
0.612
AUD – Severe
0.549
(0.384-0.708)
0.451
Cannabis Dependence
0.329
(0.223-0.455)
0.671
Cocaine Dependence
0.376
(0.235-0.553)
0.624
Opioid Dependence
0.641
(0.459-0.803)
0.359
Amphetamine
Dependence
0.353
(0.215-0.525)
0.647
Composite SUD Score 0.414
0.586
total undergraduate enrollment size was multiplied by the general attrition rate, and again
multiplied by percent of that attrition that is attributable to substance use, or about 15%
(40,41). To estimate the number of students who would avoid being lost to substance-related
attrition, the number of students who participate in the CRP multiplied by 1 minus the relapse
rate are subtracted from the total number of students lost to substance-related attrition. Figure
7 demonstrates how the effect was estimated for the institutional perspective.

Figure 8. Formula for the estimation of intervention effect in the institutional perspective.
'($)*+)($,"( 4&&)5$ = # 7$2=)($# V"#$ − (C ∗ (1 − F))

Data Analysis
Societal Perspective
Each of the point estimates discussed above form the base case cost-effectiveness
analysis. The value for each point estimate is provided in table 4. The incremental cost, or
numerator, was found by subtracting the cost of TAU from the cost of the intervention from
16

the societal perspective. The incremental effect was found by subtracting the quality-adjusted
life expectancy (QALE) in the TAU condition from the QALE in the intervention condition.
To find the incremental cost effectiveness ratio (ICER) or cost per unit of health outcome, the
incremental cost was divided by the incremental effect.
Each point estimate forming the base case model has some level of uncertainty. Due
to the scarcity of data about CRPs, the CRP modeled from the data is particularly uncertain.
To account for this uncertainty, and to understand which variables have the most impact on
the model, two types of sensitivity analysis were conducted. First, one-way sensitivity
analyses were conducted in Excel by allowing one variable to vary over a plausible range of
values while holding all other variables constant. The range of variation for each variable, as
well as the source for that variation is detailed in Table 4. After identifying the influence
each variable had over the model, critical thresholds of cost-effectiveness and cost savings
were noted. The second type of sensitivity analysis conducted was a multi-way sensitivity
analysis, in this case a Monte Carlo simulation. Each variable was allowed to vary within the
parameters in Table 4, and an ICER was calculated for each of 10,000 iterations of variation.
This allowed for the calculation of a new simulated ICER, along with a 95% confidence
interval. A triangle distribution was assumed for each variable except CRP membership,
which was assumed to be Poisson distributed. The Monte Carlo simulation was conducted in
RStudio (55), and the code is included in Appendix B.
The range of variation for each parameter was either determined from the literature or
by adding or subtracting 20% from the base case parameter (see table 4). The incremental
cost to society (Ci) range of variation is drawn from the literature, with the low estimate at
17

$15,227 and the base case at $22,436 (27,28). CRP budget variation was estimated by
calculating the average budget for the top 50% most costly programs and the average for the
bottom 50% (19). Early stage CRPs can be expected to have smaller membership sizes than

Table 4. Parameters for sensitivity analyses of the societal model.
Variable Base Case
Low
High
Source
C
$23,019,898,477 $18,415,918,781
$27,623,878,172 +/- 20%
Ci
$22,436
$15,227
$22,436
(27,28)
B
(19)
$191,389.44
$159,399.47
$223,379.40
M
8
19
(17)
14
R
0%
25%
(20)
8%
Y*
0.586
0.359
0.741
(6,38)
* Reported as quality of life adjustment used in the calculation of quality-adjusted life
expectancy.
programs that are more developed, so a mean for programs identified as early stage and a
mean for programs identified as middle to late stage were calculated as the lower and upper
bounds of variation, respectively. The reported relapse rate range is 0% - 25% (20). The
variation in life years gained is bounded by the lowest quality of life adjustment in Table 3
(“AUD – Mild”) and the highest (“Opioid Dependence”) (6).
Institutional Perspective
Each point estimate used in the base case model was collected as described in the
previous section (see table 2), and the value of each point estimate is provided in table 5. The
incremental cost, or numerator, was found by subtracting the cost of TAU from the cost of
the intervention condition. The incremental effect, or denominator, was found by subtracting
the number of students lost to substance-related attrition in the intervention condition from
the number of students lost in the TAU condition. Because this is expected to yield a
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negative value, and the outcome of interest is a positive value (number of students retained
who would have otherwise been lost to substance-related attrition), the observed value will
be subtracted from the expected value. The value of the TAU condition should then equal
zero, as the same number of students who are expected to be lost to attrition would be, and
the estimation of the intervention condition will be a positive value. Figure 9 presents the
formula used in the denominator to find incremental effect. The ICER was determined by
dividing the incremental cost by the incremental effect to find the cost per unit of effect in
the base case.

Figure 9. Calculation of the incremental effect, or denominator, for the institutional model.
.A1 = B4 ∗ AM ∗ AW H − B4 ∗ AM ∗ AW H
'($)*+)($,"( = B4 ∗ AM ∗ AW H − (B4 ∗ AM ∗ AW H − BC ∗ (1 − F)H)

The methods for the one-way sensitivity analysis and the Monte Carlo simulation
were the same for both the societal and institutional model. The parameters used in the
sensitivity analyses for the institutional model are provided in table 5, and the code used for
the Monte Carlo simulation in RStudio (55) is provided in Appendix B.
Because the cost of substance-related attrition (variable A) is a function of the rate of
substance-related attrition (variable As) and general attrition (variable Ag), only substancerelated attrition was varied in the sensitivity analyses. The range of 10% to 20% was
provided as a plausible range in the original source material (40). Opportunity costs were
varied by 20% rather than identifying plausible ranges of variation for each component of the
19

formula used to estimate these costs. No confidence interval or variance parameters were
found for the hourly wages used in the calculation of opportunity costs, so these were also
varied by 20%. The same procedure for establishing a plausible range of variation for the
CRP-specific parameters (CRP budget, membership and relapse rate) was used in both the
societal and the institutional model. An approximate range of variation from the literature
was found for enrollment sizes and tuition costs and rounded to the nearest thousand
(42,43,56,57).

Table 5. Parameters for sensitivity analyses of the institutional model.
Variable Base Case
Low
High
A
$4,404,212.05
$2,936,141.36
$5,872,282.73
As
15%
10%
20%
Os
$1,078.41
$862.73
$1,294.10
Oc
$8,393.03
$6,714.43
$10,071.64
Oa
$272.85
$218.28
$327.41
Ss
$19.59
$15.67
$23.51
Sc
$25.14
$20.11
$30.17
Sa
$30.27
$24.22
$36.32
B
$191,389.44
$159,399.47
$223,379.40
M
8
19
14
R
0%
25%
8%
E
4,551
2,000
60,000
T
$26,120
$5,000
$50,000

Source
(40)
+/- 20%
+/- 20%
(19)
(17)
(20)
(43,56)
(42,57)

Toolkit
The Cost-Effectiveness Toolkit for Collegiate Recovery Programs (the Toolkit) was
created in Excel using the methods described above for the base case calculations of
incremental cost, incremental effect, and ICER. In the societal perspective model, users may
enter their own data for an existing or proposed CRP, including CRP budget, membership
size, and relapse rate. In the institutional model, users may enter CRP data as well as data
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specific to their own institution. A worksheet for estimating institution-specific attrition costs
(variable A), opportunity costs (variable Os,c,a) is included in the Toolkit. Users may also
enter tuition costs and enrollment size specific to their institution. Appendix A provides
additional details about using the Toolkit for custom estimations of ICER.
Human Subjects
This study is a secondary analysis of existing, de-identified data. No names of
individuals or institutions will be included in any report or publication resulting from this
study. This study was reviewed by the Committee for the Protection of Human Subjects at
the University of Texas Health Science Center at Houston and was declared exempt
according to 45 CFR 46.101(b). It was approved on December 6, 2018 (IRB number HSCSPH-18-1052).
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JOURNAL ARTICLE
Collegiate Recovery Programs are a Cost-Effective Tool to Address Substance Use
Disorder in Young Adults - Addiction
Introduction
Substance use disorder (SUD) affects a substantial portion of the population (7.2%),
and is especially prevalent among undergraduate students aged 18 to 22 at 13.5% (1,2).
These disorders are estimated to cost the US $442 billion annually, in part due to rising costs
associated with treatment episodes (3–6). Further driving the costs to society are the lack of
recovery support resources that help to reduce relapse and repeat treatment episodes. Most
(63%) people have had more than one treatment episode and 15.5% had five or more
treatment episodes (7). Collegiate recovery programs (CRPs) offer a potential amelioration to
the tremendous costs to society both in terms of financial costs and lost life years, as students
and alumni of these programs tend to experience much lower relapse rates than the general
population in SUD recovery (8–10).
While CRPs are promising, little is known about the efficiency of these programs, as
no economic evaluation of CRPs has yet entered the literature. This study represents the first
such evaluation of CRP efficiency in the form of a comprehensive cost-effectiveness analysis
from the societal perspective. This paper has a companion piece examining CRP costeffectiveness from the perspective of institutions of higher education (11,12). A secondary
objective of this research was to create a toolkit for individual advocates and decision-makers
to examine the cost-effectiveness of an existing or proposed CRP using user-supplied data.
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Methods
Cost-Effectiveness Analysis
Cost-effectiveness analysis involves the estimation of a cost per unit of desired health
outcome as a measure of program efficiency (13,14). Costs are estimated for both the
treatment as usual (TAU) and intervention (CRP) scenario, as are outcomes or effects. The
incremental cost is found by subtracting the cost of TAU from the cost of the CRP scenario
(13,14). The denominator of the ratio is the difference between the intervention effect and the
TAU effect (13,14). In this case, the effect of interest is quality-adjusted life years added by
CRPs compared to TAU. The incremental cost or numerator is divided by the incremental
effect or denominator, resulting in an incremental cost-effectiveness ratio (ICER) (13,14).
Estimating Costs
Total costs to society and costs per treatment episode were drawn from the literature
(3,4,15). Only the portion of societal costs attributable to college students with SUD were
captured in the model (1). Budgets for CRPs were estimated from a 2015 survey of CRP staff
wherein 20 respondents provided sufficient information with which to estimate a total budget
for the program (16). Membership sizes for CRPs were estimated from an interval-censored
and right-censored data set, where mean values were used in place of intervals to calculate an
approximate mean (17). Previous outcome evaluation research on CRPs indicate a low
relapse rate (8%) and provide a measure of variance (8). Variables used to calculate cost are
detailed in table 1, and table 2 provides a pointe estimate for each variable.
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Estimating Effect
The outcome of interest is quality-adjusted life years (QALYs) gained by the
intervention compared to TAU (13,14). Quality of life adjustments for calculating qualityadjusted life expectancies vary widely depending on substance used and severity of the
condition, thus an average figure was used (18). The average quality of life adjustment was
calculated by first converting disability weights from Whiteford et al. to quality of life
adjustments by subtracting from 1, and scores were averaged across all conditions (18,19).
The resulting averaged SUD quality of life adjustment was entered into a life expectancy
table to gain an average life expectancy across the two relevant age groups (15 to 19 and 20
to 24) (20). The parameters used in the calculation of effect are detailed in table 1, and the
point estimate used in the base case model is provided in table 2.
Dealing with Uncertainty
Two types of sensitivity analysis were undertaken to explore uncertainty in the
model. First, one-way sensitivity analyses allowed for the exploration of how each variable
impacts the ICER when allowed to vary across a plausible range of variation, while holding
all other variables constant. The second type of sensitivity analysis conducted was a Monte
Carlo simulation to examine the impact of allowing all variables to vary simultaneously over
10,000 simulated iterations. The resulting averaged ICER and 95% confidence interval
provides an estimate that accounts for variation in all of the variables simultaneously. The
parameters used for both types of sensitivity analysis are presented in table 2.
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Results
The cost of operating a CRP in the base case is $97,586.24 less than the cost of
treatment as usual and adds just over 25 QALYs. The incremental cost-effectiveness ratio
(ICER) for the societal model in the base case is -$3,872.75, or a cost savings of $3,872.75
per QALY gained when implementing a CRP (see Table 1).
The results of the one-way sensitivity analysis are presented in Figure 1 and Table 2.
Throughout the range of variation of each of the parameters, except for CRP membership, the
utilization of a CRP was always an overall cost savings. In the case of CRP membership, the
intervention is not an overall cost savings at the lowest end of the range of variation (8
members); however, it is still cost-effective in that it is both less expensive than an additional
treatment episode, and less expensive than the commonly-used $50,000 benchmark for
acceptable cost per QALY (5,6,21). When all other parameters in the base case are held
constant, at least 10 CRP members are needed to constitute cost savings. CRP membership
held the most influence over the model compared to other variables. One-way sensitivity
analyses of effectiveness, in this case QALYs gained, were conducted but not included here.
It is an established phenomenon that when numerators are negative, one-way sensitivity
analyses of effectiveness do not produce expected results, in this case, as effectiveness
increased the intervention appeared to become more expensive (22–24).
The Monte Carlo simulation resulted in a slightly lower predicted cost savings of $2,990.94 (95% CI; -$3,073.11, -$2,908.77) over 10,000 iterations.
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Discussion
Because the ICER is negative, caused by a negative numerator in the initial CEA
calculation, there is some ambiguity to the interpretation of these results. When the cost of
the new intervention being compared to treatment as usual represents an overall cost savings,
the numerator will be negative, leading to a negative ICER. A negative ICER has been
interpreted to mean that the intervention is an overall cost savings per unit of health outcome,
but others argue that the interpretation is less straightforward (22–24). Further, measures of
effectiveness in the denominator, in this case QALYs gained, cannot be subjected to a
sensitivity analyses, as the results will be the inverse of what is expected (4-6).
The more conservative estimate of ICER in the Monte Carlo simulation may be due
to the use of triangle distribution for all simulated variables except CRP membership, which
was assumed to be Poisson distributed. The triangle distribution may provide an overly
cautious representation of the true range of variation among CRPs but must be used as the
true distribution is unknown due to the limited number of studies that capture data about CRP
operations.
The primary limitation of this study is the limited availability of data about collegiate
recovery programs. Due to the rapid growth in the field in recent years, data collection efforts
have lagged behind need. The data set from which CRP budget information was gathered
represents only 54 of the 184 currently operating CRPs, and only 20 of these respondents
provided budgetary information (16,21). Relapse rates for CRPs are even more dated,
collected in 2012 when only 29 CRPs were in operation (14). While these factors pose a
limitation to the model CRP created for use in CEA here, this limitation does not apply to
26

collegiate recovery professionals and advocates who wish to substitute their own CRP’s data
for the model CRP data used here. Interested advocates may do so by using the CostEffectiveness Toolkit for CRPs (“the Toolkit”) at <<URL forthcoming>>.
As healthcare costs continue to rise during a time when unprecedented numbers of
Americans are struggling with opioids, it is essential to find cost-effective solutions to help
prevent relapse among those who receive treatment. The wide range of variation in which
CRPs represent a cost savings compared to treatment as usual is promising to the continued
proliferation of these programs at colleges and universities across the country. A companion
article presents the institutional perspective cost-effectiveness analysis of CRPs, and both
perspectives demonstrate cost-effectiveness and cost savings (11).
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Figures and Tables
Table J1.1. Variables used in the societal perspective model.
Variable Description
C
The portion of the total financial cost to society of SUD
attributable to full-time undergraduate college students aged
18-22.
Ci
Cost of SUD per individual in the target population.
B
CRP budget
M
Mean CRP membership
R
Percent of students who experience a relapse.
Y
Number of years of quality-adjusted life expectancy in either
the TAU or CRP condition.

Source
(1,3,4,15)
(1,3,4,15)
(16)
(17)
(8)
(18,20)

Table J1.2. Parameters for sensitivity analyses of the societal model.
Variable Base Case
Low
High
Source
C
$23,019,898,477 $18,415,918,781
$27,623,878,172 +/- 20%
Ci
$22,436
$15,227
$22,436
(5,6)
B
(16)
$191,389.44
$159,399.47
$223,379.40
M
8
19
(17)
14
R
0%
25%
(8)
8%
Y*
0.586
0.359
0.741
(18,20)
* Reported as quality of life adjustment used in the calculation of quality-adjusted life
expectancy.
Table J1.3. Cost-effectiveness table for the CEA of CRPs.
Total
Incremental
Intervention
Total Cost Effectiveness Cost
Treatment as
$23.02
Usual
billion
35.66 QALE
Collegiate
Recovery
$22.991
Program
billion
60.82 QALE
-$97,593.31
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Incremental
Effectiveness

ICER

25.2 QALE

-$3872.75

Table J1.4. Results of the one-way sensitivity analysis of the societal model costeffectiveness analysis of CRPs.
Variable
Low
High
Additional Details
For every $500 increase in the incremental
TAU Cost Per
cost of TAU, CRPs represent an additional
Person
-$188.22
-$3,879.77 $256 in cost savings per QALY gained.
For every $1,000 additional in CRP budget,
only $39 less in cost savings per QALY
CRP Budget
-$2,608.22
-$5,151.89 gained.
CRP
For every CRP member gained, $820
Membership
$1,043.89
-$7,983.33 increase in cost savings.
For every 1% increase in relapse rate, $124
Relapse Rate -$4,879.11
-$1,757.05 reduction in cost savings.
Figure J1.1. One-way sensitivity analysis of the societal model of CRP Cost-Effectiveness.
Relapse Rate

CRP Membership

CRP Budget

TAU Cost Per Person

-$8,000.00

-$6,000.00

-$4,000.00
Low
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High

-$2,000.00

$0.00

$2,000.00

JOURNAL ARTICLE
Cost-Effectiveness of Collegiate Recovery Programs from the Perspective of Colleges
and Universities - Journal of American College Health
Abstract
Objective: This cost-effectiveness analysis of collegiate recovery programs (CRPs)
from the perspective of institutions of higher education was conducted to fill a critical gap in
the evaluation research on CRPs. A companion article on the cost-effectiveness of CRPs
from the societal perspective is forthcoming.1 Participants: Two existing data sets were used
to construct a model CRP for analysis.2,3 These data represent 54 and 184 CRPs from across
the US.2,3 Methods: A base model incremental cost-effectiveness ratio (ICER) was
calculated to assess cost per student retained from substance-related attrition. One-way and
multi-way (Monte Carlo simulation) sensitivity analyses explored uncertainty in the base
model and identified critical thresholds. Results: CRPs represent an overall cost savings,
with an ICER of -$11,230.93 per student retained. CRPs remain a cost-saving intervention
across a wide range of plausible variation, including in the Monte Carlo simulation (ICER = $8,196.28; 95% CI -$8467.48, -$7925.08). Conclusions: In spite of the limitations imposed
by data availability and uncertainty, CRPs are cost-effective and cost-saving across a wide
range of variation.
Keywords: Substance use disorder, recovery, collegiate recovery programs, costeffectiveness, efficiency evaluation.
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Introduction
Collegiate recovery programs (CRPs) have a long history, with the first programs
established in the 1970s and 1980s, but these programs did not proliferate widely until recent
years.3 This recent growth in the field – from approximately 29 programs in 2012 to just over
184 programs today – is in part due to increased attention paid to substance use disorders
(SUD) among young adults in light of the national public health crisis related to opioids.3–5
These programs can play a critical role in ensuring that costly interventions for SUD are less
likely to result in a recurrence of use, given that participants in these programs are less likely
to relapse than the general SUD population, and that this recovery protection carries on past
graduation.5–7
In spite of these promising outcomes, CRPs have not been as widely adopted or
supported as may be expected. For example, a minority (39%) of currently operating CRPs
report full institutionalization in the form of funding and inclusion in strategic planning
within the larger university setting.3 One possible explanation for the slow diffusion of CPRs
into the college health landscape are concerns regarding expense and efficiency. To date, no
evaluation of the efficiency of a CRP has been published in the literature, representing a
critical gap in the evaluation research on these programs.
This study represents the first evaluation of CRP efficiency in the literature, using the
method of cost-effectiveness analysis (CEA). This CEA of a CRP modeled from existing
data sources is from the perspective of institutions of higher education, and thus reports
findings in terms of students who have been retained instead of lost to substance use-related
attrition. Substance use-related attrition is believed to represent between 10% and 20% of all
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attrition cases among first-year students, though the model presented here accounts for
uncertainty in this estimate.8 A companion article assessing cost-effectiveness of CRPs from
the perspective of society, which measures the cost of a CRP per additional quality-adjusted
life year (QALY) gained, is forthcoming.1 Those who wish to assess cost-effectiveness at
their own CRP may do use by using the Cost-Effectiveness Toolkit for CRPs at <<URL
forthcoming>>.
Methods
Cost-effectiveness analysis is the method of assessing how much an intervention
costs compared to the standard method of care, in terms of cost per unit of health outcome.9,10
In this case, operating a CRP on a college campus is compared to not offering a CRP, but
offering standard services such as counseling and student conduct case management. The
cost of these services are captured as opportunity costs in the model. These costs are then
divided by the desired health outcome achieved by the intervention, in this case students
retained who would otherwise have been lost to substance-related attrition.
The first layer of analysis is the single point estimate of the incremental costeffectiveness ratio (ICER), or the cost per student retained. The cost to institutions of not
having a CRP was estimated by first calculating tuition dollars lost to substance-related
attrition, and combining that with opportunity costs of campus staff who may interact with
students in active SUD.8,11–16 The average number of undergraduate students per college
campus and the median annual tuition across the US were used in the base model.11,17
Average CRP budgets and participation sizes (also called membership) were calculated from
two national surveys of these programs, and found to be approximately 14 students, though
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there is wide variation between programs.2,3 Average relapse rates among CRP students
(8%), as well as the range of variation in relapse rates (0% - 25%), were from the literature.5
Table 1 details each of the variables in the institutional perspective model and provides a
source for each. Table 2 details the point estimate for each variable.
To account for uncertainty in model estimations, as well as to account for variation in
program size, membership, relapse rates and other variables, two types of sensitivity analysis
were conducted. First, one-way sensitivity analyses demonstrated the impact of each variable
on the overall model and the resulting ICER, and allowed for the identification of critical
thresholds of cost per unit of health outcome. Multi-way sensitivity analysis, in this case a
Monte Carlo simulation, allows all variables to vary simultaneously within a given set of
parameters. The 10,000-iteration Monte Carlo simulation was conducted in RStudio, and
provided an estimation of the variance of the overall model.18,19 Triangle distributions are
assumed for all variables in the Monte Carlo simulation, except CRP membership, which is
assumed to be Poisson distributed. The parameters for each variable used in the sensitivity
analyses are available in table 2.
Results
In the base model of cost-effectiveness of a CRP from the perspective of the
institution, the presence of a CRP saves the university $11,230.93 for each student retained
who would otherwise have been lost to substance-related attrition (ICER = -$11,230.94).
CRPs can be considered both cost-effective and an overall cost-savings. Table 3 presents the
incremental cost, incremental effectiveness, and incremental cost-effectiveness ratio (ICER)
of the base model.
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The results of the one-way sensitivity analyses are presented in Table 4 and visually
represented in Figure 1. The underlying rate of attrition from a university, the rate of attrition
attributable to substance use, and the number of undergraduate students enrolled in the
institution have no impact on the overall model: the program is equally cost-effective no
matter how these components vary. The per-student opportunity costs associated with college
or university staff whose caseloads include students who struggle with substances had little
impact on the model: for every 20% increase or decrease in per-student opportunity cost,
there was a corresponding $15 change in ICER.
Variables that exerted greater influence on the model were the cost of tuition, CRP
membership, the CRP budget, and the relapse rate for students participating in the CRP. For
every $1,000 that the cost of annual tuition increases, the cost savings to the institution
increase by $990.77. The relationship between CRP budget and ICER was also linear: for
every additional $1,000 spent on a CRP budget, there was a $77.64 reduction in cost savings
when all other variables were held constant. With all other variables constant including a
membership of 14 students, a budget of $290,000 and above is no longer a cost savings,
though may still be considered cost-effective depending on cost-per-student tolerance at an
institution. The relationships of both CRP membership and relapse rate to ICER were nonlinear. Throughout the entire range of potential values of relapse rate (0% to 25%), the ICER
remained negative representing an overall cost-savings.5
The mean ICER from the Monte Carlo simulation of 10,000 variations was $8,196.28 (95% CI -$8,467.48, -$7,925.08), representing less cost savings per student
retained than the point estimate ICER from the base model. The uncertainty introduced by
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the sparse data available for CRP parameters may contribute to the discrepancy between the
Monte Carlo simulation and the base case point estimation.
Comment
Throughout the plausible range of variation for almost all variables, CRPs represent a
substantial cost savings to the institution per student. As CRP participation drops, the
program becomes less cost-effective, though this effect can be mediated if the budget is
appropriately matched to the size of the program in terms of student participants, for
example, by maintaining appropriate staff to student ratios. Similarly, campuses with below
average tuition costs may experience reduced cost savings, as much of the savings come in
the form of avoiding lost tuition due to substance-related attrition. Because relapse rates also
exert influence over the model, care should be taken to balance appropriate staff to student
ratios with adequate resources to provide support and keep relapse rates low.
CRPs are equally cost-saving across institutions of differing sizes and with differing
rates of general or substance-related attrition. While variations in staff salaries may impact
the per-student opportunity cost, this type of cost has little impact on the model. For
institutions considering adding a CRP to their campus or deepening support for an existing
CRP, it is critical to consider thresholds of participation and appropriately matched budgets,
though the range of acceptable variation while still maintaining cost savings is wide.
Limitations and Conclusion
A negative value for incremental cost and ICER, representing an overall cost savings,
leads to some ambiguities in interpretation.20–22 The national benchmarking data available for
CRPs is limited, and thus a major limitation to this evaluation is the uncertainty inherent in
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the modeled CRP. In order to minimize uncertainty in the decision-making process, those
who wish to explore the cost-effectiveness of a CRP at one’s own institution may use the
Cost-Effectiveness Toolkit for CRPs available at <<URL forthcoming>> and substitute their
own known data. The limitation of the sensitivity analyses is related to data availability, as
well: the true range of variation and underlying probability distribution of that variation is not
known, and thus the modeled variation presented here is likely to be overly conservative. In
spite of these limitations, evidence for the efficiency of CRPs has now been added to the
literature, complementing the evidence for the effectiveness of these programs.
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Tables and Figures
Table J2.1. Institutional model parameters and sources.
Variable Name
Description
A
Attrition
Tuition lost to substance-related attrition
annually.
As
Attrition rate
Rate of substance-related attrition.
(substancerelated)
Ag
Attrition rate
Rate of general attrition.
(general)
Os
Opportunity
The opportunity cost of Student Conduct staff
cost – Student working cases attributed to substance use.
Conduct
Oc
Opportunity
The opportunity cost of counseling center staff
cost –
seeing patients for substance use-related
counseling
sessions.
services
Oa
Opportunity
The opportunity cost of law enforcement for
cost – arrests
substance-related arrests on campus.
Ss,c,a
Per-student
Per-student opportunity cost for each type of
opportunity
opportunity cost described above.
cost
E
Enrollment
Undergraduate enrollment.
T

Tuition

Cost of tuition for 1 year.

Source
8,23

11,14

12,16

11,13

See above
11
24

Table J2.2. Parameters for the base case and sensitivity analyses of the institutional model.
Variable Base Case
Low
High
Source
A
$4,404,212.05
$2,936,141.36
$5,872,282.73 8
As
15%
10%
20%
Os
$1,078.41
$862.73
$1,294.10
+/- 20%
Oc
$8,393.03
$6,714.43
$10,071.64
Oa
$272.85
$218.28
$327.41
Ss
$19.59
$15.67
$23.51
+/- 20%
Sc
$25.14
$20.11
$30.17
Sa
$30.27
$24.22
$36.32
2
B
$191,389.44
$159,399.47
$223,379.40
3
M
14
8
19
Monte Carlo
3,25
14
1
100
One-Way
5
R
0%
25%
8%
11,26
E
4,551
2,000
60,000
24,27
T
$26,120
$5,000
$50,000
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Table J2.3. Cost effectiveness table for collegiate recovery programs from the perspective of
institutions of higher education.
Total
Incremental Incremental
Intervention Total Cost
Effect
Cost
Effectiveness ICER
Absence of
a CRP
$4,413,656.92
0
N/A
N/A
N/A
Presence of
a Collegiate
Recovery
13 students
Program
$4,267,654.79
13
-$146,002.13 retained
-$11,230.93

Table J2.4. One-way sensitivity analysis of the cost-effectiveness of collegiate recovery
programs: a description of the impact of each variable on the model.
Variable
Low
High
Additional Details
Tuition
As tuition increases, CRPs become a more
cost saving alternative. For every $1,000
increase in tuition, $990.77 increase in cost
savings. When annual tuition and fees fall at
or below $14,000, the intervention is not a
cost savings when other variables are held
$9,297.81
-$24,388.35 constant.
Per-Student
For every 20% increase in the per-student
Opportunity
opportunity cost, the cost savings increase by
Cost
-$11,320.57 -$11,350.57 $15, and the inverse is also true.
CRP Budget
For every additional $1,000 spent on a CRP
budget, there is a $77.64 decrease in cost
-$13,819.26 -$8,851.88
savings per student retained.
CRP
Non-linear relationship between membership
Membership
and ICER. The critical threshold below
which the intervention is no longer a cost
savings is 10 members, but still cost-effective
-$191.00
-$15,245.95 above 2 members.
Relapse
Non-linear relationship between relapse rate
Rate
and ICER. The critical threshold below
which the intervention is no longer a cost
savings is a relapse rate of 40%. The
intervention remains cost-effective at or
-$12,524.32 -$7,967.43
above a relapse rate of 81%.
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Figure J2.1. One-way sensitivity analysis of the cost-effectiveness of collegiate recovery
programs, presenting only variables that impact the model.
Tuition
Per-Student Opp. Cost
CRP Budget
Membership
Relapse Rate
-$25,000

-$20,000

-$15,000

-$10,000
High
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Low

-$5,000

$0

$5,000

$10,000

CONCLUSION
From both the societal and institutional perspectives, CRPs are not only costeffective, but also cost-saving, even over a wide range of variation to account for relatively
high amounts of uncertainty in the data. CRP membership size, CRP budget, and relapse rate
impact the cost-savings and cost-effectiveness of CRPs compared to TAU in both the societal
and institutional perspective models, thus it is important to ensure that CRP hiring practices
and budget allocations are an appropriate fit for the membership size. Similarly, it is
important to maintain adequate staff to student ratios and provide sufficient resources to CRP
operations in order to keep relapse rates contained.
The cost of TAU and tuition also impact the cost-effectiveness and cost savings
provided by the intervention. When the cost of additional treatment episodes in the societal
perspective model, or the cost of tuition in the institutional perspective model, becomes less
expensive, then CRPs represent less of a cost savings and are less cost-effective; however,
with both healthcare costs and tuition costs continuing to rise, it is unlikely that these costs
will become so inexpensive as to become dominant relative to CRPs.
Given the uncertainty in the data gathered, particularly in the data used to model a
typical CRP, the Toolkit provides a tool for advocates seeking to reduce uncertainty by
inputting their own data into the models. The primary limitation of this research was the
availability of data on CRPs. Only 20 CRPs provided sufficient information from which to
estimate a total budget, and CRP membership size was estimated from interval-censored and
right-censored data (17,19). One strength of this research is that this uncertainty was
explored in depth in two types of sensitivity analyses, and that the cost-effectiveness and
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cost-savings found in the base model were retained throughout a wide range of variation. The
greatest strength of this research is that it represents the first evaluation of CRP efficiency to
enter the literature and may spur additional research into the economics of these programs.
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APPENDICES
Appendix A: The Cost-Effectiveness Toolkit for Collegiate Recovery Programs.
The Cost-Effectiveness Toolkit for Collegiate Recovery Programs (“the Toolkit”) is
available at <<URL forthcoming>> and is intended to allow advocates to calculate a specific
ICER for their own institution as it currently operates, or to project an ICER for a proposed
CRP not yet in operation. The Toolkit contains four tabs: User-Supplied Data, Base Model,
Worksheet, and References. The User-Supplied Data tab is where advocates can enter their
own real or proposed CRP parameters for either the societal perspective or institutional
perspective model, or for both. The Base Model tab provides point estimates for the base
case, an estimate of the parameter for a small CRP or a large CRP if applicable, and the range
of variation for that parameter used in the Monte Carlo simulation. The Worksheet tab
provides a worksheet for users to estimate the cost of tuition lost to substance-related
attrition, adapted from the Everfi (n.d.) attrition calculator, as well as a worksheet to estimate
opportunity costs related to substance use on campus. The references tab provides full
bibliographic references for each of the point estimates and the estimates of the range of
variation, where applicable.
The User-Supplied Data tab contains two workspaces: Model 1 – Societal Perspective
(see Figure A1) and Model 2 – Institutional Perspective (Figure A2). Only cells highlighted
in either yellow or blue may be modified by the user. In both the societal and institutional
perspective model, the individual institution’s actual or proposed CRP budget, membership
size, and relapse rate may be entered. Greater customization is available in Toolkit for the
institutional perspective model: the substance-related attrition cost, opportunity cost, tuition,
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enrollment size, and substance-related and general attrition costs can be customized in
addition to the variables mentioned above. The ICER generated from the institution model
calculation can then be considered highly customized to that specific institution’s parameters.

Figure A1. Societal Perspective customizable model in The Cost-Effectiveness Toolkit for
Collegiate Recovery Programs.
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Figure A2. Institutional Perspective customizable model in The Cost-Effectiveness Toolkit
for Collegiate Recovery Programs.
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Appendix B. R code used for the Monte Carlo simulation.
Monte Carlo for CEA of CRPs
library("triangle",
lib.loc="/Library/Frameworks/R.framework/Versions/3.5/Resources/li
brary")
library(sn)
set.seed(123)

Societal Perspective
mc_societal_basecase<-data.frame(
cost_tau = c(rtriangle(n=10000,a=18415918781.73,b=27623878172.59,c=23019
898477.16)),
cost_pp = c(rtriangle(n=10000,a=17949.24,b=26923.86,c=22436.55)),
budget = c(rtriangle(10000,a=159399.47,b=223379.40 , c=191389.44)),
memb = c(rpois(10000,8:19)),
relapse = c(rtriangle(n=10000,a=0.75,b=1,c=0.92)),
qalys_added = c(rtriangle(n=10000,a=15.75185654,b=38.98432449,c=25.2))
)
mcsoc<-mc_societal_basecase
mcsoc$icost<-(mcsoc$cost_tau-((mcsoc$memb*mcsoc$relapse)*mcsoc$cost_pp)+mc
soc$budget)-mcsoc$cost_tau
mcsoc$ieffect<-mcsoc$qalys_added
mcsoc$icer<-mcsoc$icost/mcsoc$ieffect
mcm<-mean(mcsoc$icer)
print(mcm)
#mean= -2990.941
mcsd<-sd(mcsoc$icer)
print(mcsd)
#sd = 4192.469
mcz<-1.96
mcme<-(mcz*mcsd)/sqrt(10000)
mccih<-mcm+mcme
mccil<-mcm-mcme
print(mccil)
# -3073.113
print(mccih)
# -2908.769

Institutional Perspective
nat_stu_conduct_subs <-(56038+184681)
nat_arr_subs <-(19423+19992)
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oppcost_pp_cond <- c(rtriangle(n=10000,a=15.67,b=23.51,c=19.59))
oppcost_pp_couns <- c(rtriangle(n=10000,a=20.11,b=30.17,c=25.14))
oppcost_pp_arr <- c(rtriangle(n=10000,a=24.22,b=36.32,c=30.27))
budget <- c(rtriangle(10000,a=159399.47,b=223379.40 , c=191389.44))
memb <- c(rpois(10000,8:19))
relapse <- c(rtriangle(n=10000,a=0.75,b=1,c=0.92))
enrollment <- c(rtriangle(n=10000,a=2000,b=60000,c=31000))
tuition <- c(rtriangle(n=10000,a=5000,b=50000,c=26120))
gen_attrition <- c(rtriangle(n=10000,a=0.18525,b=0.30875,c=0.247))
subs_attrition <- c(rtriangle(n=10000,a=0.1,b=0.2,c=0.15))
mci_bc1<-data.frame(
attrition = c(tuition*(enrollment*gen_attrition*subs_attrition)),
attributable_to_school = c(enrollment/19900000)
)
mci_bc<-data.frame(
tot_oppcost_cond = c(nat_stu_conduct_subs*mci_bc1$attributable_to_school
*oppcost_pp_cond),
tot_oppcost_couns = c((((enrollment*0.1206)*5.53)*0.11)*oppcost_pp_couns
),
tot_oppcost_arr = c(nat_arr_subs*mci_bc1$attributable_to_school*oppcost_
pp_arr)
)
inst_mc<-data.frame(
tot_oppcost_cond = c(mci_bc$tot_oppcost_cond),
tot_oppcost_couns = c(mci_bc$tot_oppcost_couns),
tot_oppcost_arr = c(mci_bc$tot_oppcost_arr),
attrition = c(mci_bc1$attrition),
attrib = c(mci_bc1$attributable_to_school),
oppcost_pp_cond =c(oppcost_pp_cond),
oppcost_pp_couns = c(oppcost_pp_couns),
oppcost_pp_arr =c(oppcost_pp_arr),
budget =c(budget),
memb=c(memb),
relapse=c(relapse),
enrollment=c(enrollment),
tuition=c(tuition),
gen_attrition=c(gen_attrition),
subs_attrition=c(subs_attrition)
)
inst_mc$DoNothingCost<-(inst_mc$attrition+
inst_mc$tot_oppcost_arr+
inst_mc$tot_oppcost_couns+
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inst_mc$tot_oppcost_cond)
inst_mc$CRPCost<-(inst_mc$DoNothingCost(inst_mc$tuition*
inst_mc$memb*inst_mc$relapse)((inst_mc$memb*inst_mc$relapse)*
(inst_mc$oppcost_pp_cond+
inst_mc$oppcost_pp_arr+
inst_mc$oppcost_pp_couns))+
inst_mc$budget)
inst_mc$icost<-inst_mc$CRPCost-inst_mc$DoNothingCost
inst_mc$DoNothingEffect<-(inst_mc$enrollment*inst_mc$gen_attrition*inst_mc
$subs_attrition)(inst_mc$enrollment*inst_mc$gen_attrition*inst_mc$subs_attrition)
inst_mc$CRPEffect<-round((
inst_mc$enrollment*inst_mc$gen_attrition*inst_mc$subs_attrition)((inst_mc$enrollment*inst_mc$gen_attrition*inst_mc$subs_attrition)(inst_mc$memb*inst_mc$relapse)),0)
inst_mc$ieffect<-(inst_mc$CRPEffect-inst_mc$DoNothingEffect)
inst_mc$ICER<-(inst_mc$icost/inst_mc$ieffect)
mcm_inst<-mean(inst_mc$ICER)
print(mcm_inst)
#mean= -8196.281
mcsd_inst<-sd(inst_mc$ICER)
print(mcsd_inst)
#sd = 13836.75
mcz<-1.96
mcme_inst<-(mcz*mcsd_inst)/sqrt(10000)
mccih_inst<-mcm_inst+mcme_inst
mccil_inst<-mcm_inst-mcme_inst
print(mccil_inst)
# -8467.481
print(mccih_inst)
# -7925.081
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